Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$60.6M |
| 2 |
CoStar Group
CSGP
|
+$57.8M |
| 3 |
Consolidated Edison
ED
|
+$52.3M |
| 4 |
Deere & Co
DE
|
+$44.5M |
| 5 |
Exelon
EXC
|
+$42.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Amazon
AMZN
|
+$366M |
| 3 |
Moderna
MRNA
|
+$123M |
| 4 |
Entergy
ETR
|
+$44.9M |
| 5 |
Linde
LIN
|
+$43.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.98% |
| 2 | Industrials | 10.54% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Financials | 9.11% |
| 5 | Healthcare | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLC
1676
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $259K | ﹤0.01% |
+38,041
| New | +$223K |
|
|
ATRI
1677
DELISTED
Atrion Corp
ATRI
| $259K | ﹤0.01% |
+372
| New | +$247K |
|
|
POL
1678
DELISTED
Polished.com Inc.
POL
| $259K | ﹤0.01% |
+1,648
| New | +$248K |
|
1679
HealthEquity
HQY
$8.81B
| $258K | ﹤0.01% |
+3,990
| New | +$277K |
|
1680
Howard Hughes
HHH
$3.99B
| $257K | ﹤0.01% |
+3,074
| New | +$266K |
|
1681
Simulations Plus
SLP
$372M
| $256K | ﹤0.01% |
+6,474
| New | +$295K |
|
|
ITCI
1682
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $256K | ﹤0.01% |
+6,859
| New | +$238K |
|
|
NTUS
1683
DELISTED
Natus Medical Inc
NTUS
| $256K | ﹤0.01% |
10,194
-25,893
| -72% | -$660K |
|
1684
Omnicom Group
OMC
$24.4B
| $255K | ﹤0.01% |
+3,526
| New | +$262K |
|
|
ZYXI
1685
DELISTED
Zynex
ZYXI
| $255K | ﹤0.01% |
24,646
+5,328
| +28% | +$68.5K |
|
|
KBAL
1686
DELISTED
Kimball International
KBAL
| $254K | ﹤0.01% |
+22,679
| New | +$279K |
|
1687
Stevanato
STVN
$6.08B
| $253K | ﹤0.01% |
+10,008
| New | +$236K |
|
1688
Unisys
UIS
$192M
| $253K | ﹤0.01% |
10,082
-33,765
| -77% | -$799K |
|
1689
Universal Insurance Holdings
UVE
$1.21B
| $251K | ﹤0.01% |
19,254
-24,248
| -56% | -$331K |
|
1690
First Advantage
FA
$3.55B
| $250K | ﹤0.01% |
13,148
-26,119
| -67% | -$548K |
|
1691
Infosys
INFY
$47.9B
| $250K | ﹤0.01% |
+11,236
| New | +$254K |
|
1692
Tilly's
TLYS
$114M
| $250K | ﹤0.01% |
17,859
+5,573
| +45% | +$84.6K |
|
|
TE
1693
T1 Energy
TE
$1.27B
| $250K | ﹤0.01% |
+25,300
| New | +$233K |
|
|
FTVIU
1694
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
| $250K | ﹤0.01% |
25,000
| – | – |
|
|
OSTRU
1695
DELISTED
Oyster Enterprises Acquisition Corp. Unit
OSTRU
| $250K | ﹤0.01% |
25,000
| – | – |
|
1696
Marcus & Millichap
MMI
$1.23B
| $249K | ﹤0.01% |
6,124
-5,494
| -47% | -$213K |
|
1697
Trupanion
TRUP
$1.39B
| $248K | ﹤0.01% |
+3,197
| New | +$315K |
|
1698
MoonLake Immunotherapeutics
MLTX
$1.31B
| $247K | ﹤0.01% |
25,000
| – | – |
|
1699
Vishay Precision Group
VPG
$881M
| $247K | ﹤0.01% |
7,101
+256
| +4% | +$9.29K |
|
|
RMGCU
1700
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
| $247K | ﹤0.01% |
25,000
| – | – |
|
Similar funds
Michael Gelband's Q3 2021 Portfolio in Review
As of Q3 2021, Michael Gelband held 2,951 positions worth $7.41B, down 18% from $9.04B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Michael Gelband withdrew a net $1.27B in Q3 2021, closing 919 positions and reducing 594 holdings. Its most notable exit was Amazon, an estimated $366M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Michael Gelband opened a new position in Advanced Micro Devices worth $61M.
- Michael Gelband's largest Q3 2021 buy was Advanced Micro Devices: 592,990 shares worth $61M.
- Michael Gelband added most to CoStar Group in Q3 2021, an estimated $57.8M increase.
- Michael Gelband's biggest Q3 2021 reduction was Microsoft, cutting an estimated $483M.
- Michael Gelband fully exited Amazon in Q3 2021, selling an estimated $366M.
- Michael Gelband's ten largest holdings make up 9.8% of its $7.41B portfolio in Q3 2021.
- Michael Gelband opened 679 new positions and closed 919 in Q3 2021.
- Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.41B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.